Codes / ICD10CM / C85.05

C85.05 Lymphosarcoma, lymph nodes of inguinal region and lower limb

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lymphosarcoma, lymph nodes of inguinal region and lower limb
  • C85.05

Summary

Lymphosarcoma, lymph nodes of inguinal region and lower limb, is a type of non-Hodgkin lymphoma (NHL) that specifically involves the lymph nodes in the inguinal region (groin) and lower limb. This condition affects the lymphatic system, part of the immune system, and involves abnormal growth of lymphoid cells. The term "lymphosarcoma" is a historical classification now categorized under NHL.

Causes

The exact cause of lymphosarcoma in the inguinal region and lower limb lymph nodes is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

  • Advanced age (more common in older adults)
  • Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
  • Certain infections (e.g., Epstein-Barr virus, H. pylori)
  • Exposure to chemicals (e.g., pesticides, herbicides)
  • Family history of lymphoma
  • Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

  • Swollen lymph nodes in the groin or lower limb
  • Fever, night sweats, or unexplained weight loss
  • Fatigue or weakness
  • Pain or discomfort in the affected area
  • Skin changes or ulcers near swollen nodes
  • Reduced mobility or swelling in the lower limb

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI), and biopsy of the affected lymph node. Blood tests may also be performed to assess overall health and rule out other conditions. A pathologist examines the biopsy sample to confirm the presence of lymphoma and determine its subtype.

Treatment Options

Treatment depends on the stage and subtype of lymphoma and may include chemotherapy, immunotherapy, radiation therapy, or a combination of these. Targeted therapies or stem cell transplantation may be considered for advanced cases. Treatment plans are tailored to the individual’s overall health and specific disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on factors such as the lymphoma subtype, stage at diagnosis, and response to treatment. Regular follow-up appointments are essential to monitor for recurrence or complications. Long-term surveillance may include periodic imaging or blood tests to assess treatment effectiveness and detect any new developments.

Complications

Potential complications include infection due to a weakened immune system, organ damage from tumor growth, or side effects from treatment (e.g., fatigue, nausea, or neuropathy). In advanced cases, lymphoma may spread to other parts of the body, affecting multiple organ systems.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and stress management, may support overall well-being during treatment. Avoiding known risk factors, such as excessive chemical exposure, and practicing good hygiene can help reduce infection risk. Vaccinations (e.g., flu, pneumonia) may be recommended to protect against infections.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or pain in the groin or lower limb. Prompt evaluation is important for early diagnosis and treatment. Contact a healthcare provider if symptoms worsen or new concerning signs (e.g., difficulty walking or severe swelling) develop.

Tips for Medical Coders

When coding C85.05, ensure the documentation specifies lymphosarcoma involving the inguinal region and lower limb lymph nodes. Verify that the diagnosis aligns with the anatomical location and that no other specific lymphoma subtypes are documented, as this code is site-specific. Confirm that the code is used for primary lymphoma in these regions and not for metastatic disease from another site.

Book a walkthrough

C85.05 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.